On May 16, 2019, the Board of Directors of CEN Biotech, Inc. appointed Alex Tarrabain, one of the members of the Company's Board to serve as the Company's Chief Financial Officer and as one of the Vice Presidents of the Company effective May 21, 2019. Richard Boswell served as the Company's Chief Financial Officer since July 2017, resigned from his position as the Company's Chief Financial Officer as of the Effective Date, and will continue to serve in his position as the Company's Senior Executive Vice President going forward focusing on the Company's strategic activities and will also continue to serve as a member of the Company's Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -93.75% | -.--% | -93.33% |
- Stock Market
- Equities
- CENBF Stock
- News CEN Biotech, Inc.
- CEN Biotech, Inc. Announces Executive Changes